Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-163713
Filing Date
2026-04-20
Accepted
2026-04-20 15:00:03
Documents
1
Period of Report
2026-04-16

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4611
  Complete submission text file 0001193125-26-163713.txt   6217
Mailing Address C/O AXOVANT SCIENCES, INC. 1441 BROADWAY, 3RD FLOOR NEW YORK NY 10018
Business Address
Modig Berndt (Reporting) CIK: 0001643072 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40010 | Film No.: 26874739

Mailing Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN Netherlands
Business Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN Netherlands 31 (0)71 203 6410
Pharvaris N.V. (Issuer) CIK: 0001830487 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)